Rise of High-Priced ATMPs Fuels Demand for More Flexible and Equitable HTA Mechanisms
Summary
Over the past few years, the growing influx of advanced therapy medicinal products (ATMPs) has delivered substantial advances in terms of treatment options and even cures for diseases that previously lacked effective therapies. However, these ATMPS often carry substantial development or production costs, and the need for the pharma industry to recover these costs can severely restrict their adoption by health authorities around the world. As such, demand has risen for new, more flexible, more equitable health technology assessment (HTA) mechanisms, which would allow ATMPs to be brought to a much wider patient population.
This product is a market research report. Each license type allows a set number of users to access the report. Please select an option from the list below. This product is a market research report. This is a single user license, allowing one user access to the product. The product is a PDF. This product is a market research report. This is a site license, allowing all users within a given geographical location of your organization access to the product. The product is a PDF. This product is a market research report. This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF.
The sample excerpt is provided to help you make an informed purchasing decision. It is not intended to serve as free content or replace a full report. To ensure the sample aligns with your specific needs, our team will contact you to better understand your requirements.
An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net
This report can be tailored to focus on a specific country, region, continent, or provide global coverage. Please indicate your regions of interest and share any additional questions you may have. Our team strives to respond to all inquiries within the same business day.
An error occurred while sending the message. Should this issue persist, email us at help@researchandmarkets.net
